SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 57 filers reported holding SIO GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,220 | +30.5% | 12,000 | -23.1% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 15,600 | -6.6% | 0.00% | – |
| Q2 2022 | $6,000 | -50.0% | 16,700 | -8.7% | 0.00% | – |
| Q1 2022 | $12,000 | -53.8% | 18,300 | -9.0% | 0.00% | – |
| Q4 2021 | $26,000 | -76.8% | 20,100 | -61.2% | 0.00% | – |
| Q3 2021 | $112,000 | -21.7% | 51,800 | -1.0% | 0.00% | – |
| Q2 2021 | $143,000 | +4.4% | 52,325 | 0.0% | 0.00% | – |
| Q1 2021 | $137,000 | -6.2% | 52,325 | -0.6% | 0.00% | – |
| Q4 2020 | $146,000 | – | 52,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sassicaia Capital Advisers LLC | 310,500 | $863,000 | 1.79% |
| Consonance Capital Management LP | 3,186,335 | $8,858,000 | 0.83% |
| Opaleye Management Inc. | 2,000,000 | $5,560,000 | 0.73% |
| Sio Capital Management, LLC | 886,665 | $2,465,000 | 0.50% |
| Rubric Capital Management LP | 2,335,200 | $6,492,000 | 0.48% |
| Affinity Asset Advisors, LLC | 250,000 | $695,000 | 0.37% |
| GSA CAPITAL PARTNERS LLP | 354,265 | $985,000 | 0.16% |
| Hudson Bay Capital Management LP | 3,200,000 | $8,896,000 | 0.05% |
| Insight Advisors, LLC/ PA | 24,000 | $67,000 | 0.02% |
| Maven Securities LTD | 86,788 | $246,000 | 0.02% |